Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
about
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversalThe sulphonylurea glibenclamide inhibits multidrug resistance protein (MRP1) activity in human lung cancer cellsMechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletionThe P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondiiKnocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretionTargeting multidrug resistance in cancerIdentification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cellsBlock copolymeric biotransport carriers as versatile vehicles for drug delivery.Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.The role of drug efflux pumps in acute myeloid leukemia.Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.Glutathione conjugates and their synthetic derivatives as inhibitors of glutathione-dependent enzymes involved in cancer and drug resistance.Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacinMolecular and cellular physiology of renal organic cation and anion transport.Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance.Molecular pharmacokinetics of catharanthus (vinca) alkaloids.The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.Natural and synthetic polymers as inhibitors of drug efflux pumps.Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/PgpLocalization of multidrug resistance-associated protein 2 in the nonpigmented ciliary epithelium of the eye.Effect of pluronic P85 on ATPase activity of drug efflux transporterspH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance.An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump.New-generation efflux pump inhibitors.Mechanism of active renal tubular efflux of tenofovir.In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs).Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines.Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.
P2860
Q21246014-015BD4B7-C133-43BD-A144-90CC8CF317C6Q28346503-CEA8BE1E-00F9-4BE3-BC00-4A3D96E0DA63Q28366592-68FE29C0-AEE1-4FEE-A64C-E40C18229165Q28473611-E10DC41B-7F45-4DE0-A67C-C0D3A6C385F0Q28570070-3991F92D-3732-425F-887E-6F730FFE9319Q29616803-8A1A20B8-B390-40FF-8313-A80D9B48D70AQ33476723-DDFB4557-2ECC-40F5-BACF-BB4C32308EE8Q34394090-16E28E6D-EF86-4923-8865-525875C3D8DAQ34451869-69F8599E-1C72-46DA-A3E4-06679D2912E5Q34761824-953121A3-653F-466B-A673-EE879A1537EEQ34769834-A69E0C72-1333-4BC7-B6BA-407E017527AFQ34803651-C02A125D-42A5-4A31-8E97-B75647C6A76CQ34970234-809D93B7-EC18-4824-8D30-C20F877B97F1Q35027940-7B628D08-5B0D-44C7-B75E-5328B2BE3800Q35047028-5ED54D14-F615-44F1-9458-CBFEE9514B4BQ35096121-B881DF7C-AF76-4A81-B576-39B8DEF1F1CDQ35187902-1A508C55-F50D-4DA0-8533-378333ADB954Q35204550-AA4ED2CF-0DCC-4693-92A1-1882DD417173Q35374935-F866F524-34CF-4A0B-B228-49334F246625Q35842999-71185F52-3983-47C5-84F5-E86BB7A9779CQ35912731-DF51574B-C74E-4935-854B-542F2268CBFEQ36103906-1D9E23FA-591B-4EB7-A770-B8D940EB75C3Q36300799-8BE3C58B-ED62-4D3D-8B29-21177EC7C30BQ36572571-032FA78A-BF62-43D6-9C5F-0DA26AFF3D7AQ36795140-EDA94D24-622C-4529-B776-2F57E4B38DC4Q36935258-3CCE846F-A50F-4FDD-8C86-3C821E7BA949Q36951710-53A451A9-249E-4C14-89E6-EB4194E53C65Q37021815-76740777-8FED-456B-8C45-18D2F6BAE545Q37168510-00C6AA7F-95EA-4FD5-BEEE-91C64745C000Q37179672-5EDE25FA-E2DE-4539-9DC9-BF939B0A94C3Q37640892-662D47DD-C3F6-4359-8331-AD0F2943FB6AQ37714185-293DCC71-C448-4539-B893-565F35334A1DQ37725822-AB55EB9C-1C20-4BD9-B589-AFDAF8CDAAEBQ38178317-C03840C2-5CC7-4CC8-B48F-C7C581B1D4FAQ38665179-A243B6E1-1267-4F93-A920-B4F8D97A87F2Q38758994-99175A22-18B5-414E-936E-FFAB443D1E3AQ39326387-443A44BC-8D26-44B0-903C-339BA4D9E385Q39351259-4301804F-B2E8-4AB7-9965-80118B3F2FD8Q39599792-8791D502-B665-4952-B482-A6BF444EF571Q39789933-AC7DAEC8-C4E1-42BA-BBA7-40B8EECEEA53
P2860
Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@ast
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@en
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@nl
type
label
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@ast
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@en
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@nl
prefLabel
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@ast
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@en
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@nl
P2093
P2860
P3181
P356
P1476
Inhibitory effect of the rever ...... 1- and MRP2-mediated transport
@en
P2093
P2860
P2888
P304
P3181
P356
10.1054/BJOC.2000.1260
P407
P577
2000-08-01T00:00:00Z
P5875
P6179
1023516158